Compared with control subjects, the systemic sympathetic nervous system is activated in patients with mitral regurgitation - 28/08/11

Abstract |
Background |
Whether the systemic sympathetic nervous system is activated as a compensatory mechanism in response to mitral regurgitation (MR) in humans is unknown. We tested the hypotheses that the systemic sympathetic nervous system would be activated in patients with MR in comparison with control subjects and that this activation would occur early in the disease process as a compensatory mechanism for chronic left ventricular (LV) volume overload.
Methods |
We studied 37 patients with MR who underwent right heart catheterization and biplane cineventriculography to obtain LV end-diastolic and end-systolic volumes, ejection fractions, and regurgitant volumes. In these 37 patients with MR and in 23 control subjects, an [3H]-norepinephrine ([3H]-NE) infusion and multiple arterial blood samples provided data for a 2-compartment modeling analysis to calculate extravascular NE release rates (NE2).
Results |
The mean NE2 (2.05 ± 0.76 μg/min/m2) in the patients with MR was greater than that in the control subjects (1.48 ± 0.75 μg/min/m2, P = .007). Furthermore, the mean NE2 values were also greater in the patients with MR who were in clinical class I (P = .05), with a pulmonary capillary wedge pressure <12 mm Hg (P = .05) or a LV ejection fraction ≥0.60 (P = .06) compared with the control subjects. The mean NE2 values were increased further in patients with MR who had a LV ejection fraction <0.60 (P = .02).
Conclusions |
The systemic sympathetic nervous system is activated in patients with MR in comparison with control subjects, and this activation appears to occur early in the disease process as a compensatory mechanism for LV volume overload.
Le texte complet de cet article est disponible en PDF.Plan
| Supported by grants from the National Heart, Lung, and Blood Institute (RO1-HL36450), the Kughn Clinical Research Center (MM-RR00042), and the National Institute of Aging (K24-AG00924), the National Institutes of Health, Bethesda, Md, and Veterans Affairs, Washington, DC. |
Vol 145 - N° 6
P. 1078-1085 - juin 2003 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?
